4 research departments
750 employees
45 nationalities
55 research teams
16 ERC laureates
260 publications per year
24000 m² lab area

Support us through

Fondation universite de Strasbourg

Communication Service

Tél. +33(0) 3 88 65 35 47

Quick Links

Science & society

Key figures 2017

12 prizes and distinctions
3 public events
26 major scientific news

Scientific news

Chemotherapy implicated in the appearance of certain metastases

Hinrich Gronemeyer

Senescence-associated reprogramming promotes cancer stemness.

Milanovic M(1), Fan DNY(1)(2)(3)(4), Belenki D(1), Dabritz JHM(1), Zhao Z(5), Yu Y(6), Dorr JR(1), Dimitrova L(7), Lenze D(7), Monteiro Barbosa IA(8), Mendoza-Parra MA(9), Kanashova T(6), Metzner M(1), Pardon K(1), Reimann M(1), Trumpp A(2)(3)(4)(10), Dorken B(1)(2)(4)(6)(11), Zuber J(8), Gronemeyer H(9), Hummel M(2)(4)(7)(11), Dittmar G(6)(12), Lee S(1)(2)(4)(6), Schmitt CA(1)(2)(4)(6)(11).

Nature Jan. 4, 2018


Dec. 20, 2017

Hinrich Gronemeyer, team leader at the IGBMC, contributed to an article published on 20 December 2017 in Nature.

A group of researchers from Germany, Austria, the United States, Luxembourg and France studied the behavior of cells undergoing chemotherapy. They highlighted a link between chemotherapy and the development of metastases.

A report in the IGBMC laboratories.

Watch the video

Imprimer Envoyer

Université de Strasbourg
INSERM
CNRS

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr